HBM Healthcare Investments AG / Fundamentals

    Income statement

    Net revenue
    -€155.34M
    Cost of goods sold
    €1.43M
    Gross profit
    -€156.42M
    SG&A expenses
    €2.29M
    R&D expenses
    €0.00
    EBITDA
    -€204.87M
    D&A
    €2.87M
    EBIT
    -€158.04M
    Interest expenses
    €1.43M
    EBT
    -€159.12M
    Tax expenses
    €46.42M
    Net income
    -€159.12M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €50.22M
    Changes in working capital
    €0.00
    Operating cash flow
    -€1.66M
    Capex
    €0.00
    Other investing cash flow
    €79.01M
    Net investing cash flow
    €79.01M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €0.00
    Debt repayment
    €54.12M
    Other financing cash flow
    -€1.19M
    Net financing cash flow
    -€28.55M
    Foreign exchange effects
    €0.00
    Net change in cash
    €47.95M
    Cash at end of period
    €60.53M
    Free cash flow
    -€1.66M

    Balance sheet

    Cash and cash equivalents
    €60.53M
    Cash and short-term investments
    €60.53M
    Total receivables
    €87.67K
    Inventory
    €0.00
    Other current assets
    €0.00
    Total current assets
    €60.61M
    Property, plant & equipment
    €0.00
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €1.74B
    Other non-current assets
    €0.00
    Total non-current assets
    €1.74B
    Total assets
    €1.80B
    Accounts payable
    €0.00
    Short-term debt
    €64.94M
    Other current liabilities
    -€64.94M
    Total current liabilities
    €0.00
    Long-term debt
    €107.82M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €121.60M
    Total non-current liabilities
    €229.43M
    Total liabilities
    €229.43M
    Common stock
    €14.59M
    Retained earnings
    €1.45B
    Other equity
    €112.59M
    Total equity
    €1.57B
    Total liabilities and shareholders' equity
    €1.80B

    Company information

    Market capitalization
    €1.24B
    Employees
    0
    Enterprise Value
    €1.20B

    Company ratios

    Gross margin
    100.7% Even with peer group: 96.1%
    EBITDA margin
    131.9% Much better than peer group: 31.5%
    EBIT margin
    101.7% Better than peer group: 85.7%
    EBT margin
    102.4% Much worse than peer group: 240.1%
    Net margin
    102.4% Much worse than peer group: 236.9%
    ROE
    -10.1% Much worse than peer group: 26.5%
    ROA
    -8.8% Much worse than peer group: 14.5%
    Asset turnover
    -8.6% Much worse than peer group: 58.3%
    FCF margin
    1.1% Much worse than peer group: 72.4%
    FCF yield
    -0.1%
    Efficiency ratio
    -31.9%
    Net sales per employee
    €0.00
    Net income per employee
    €0.00

    Notifications